GlassScriptPhysician profile
Andrii Labchuk
NPI 1780262550
$974.10
in general payments reported to CMS, 2019-2025
13 companies · $564 in 2025
The $564 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $153 · 2024: $257 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $675 · Education: $146.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $675.17 |
| Education | $145.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $188.87 | 2025 | Ensite, Cardiomems, Amplatzer |
| Inari Medical, INC. | $179.17 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medicure Pharma INC. | $153.13 | 2022 | |
| Boston Scientific Corporation | $145.52 | 2025 | Opticross 6 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $72.59 | 2024-2025 | Lifevest |
| Kestra Medical Technology Services, INC. | $49.80 | 2024 | Assure Wcd |
| Zoll Circulation INC | $38.87 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Cvrx, INC. | $29.91 | 2025 | Barostim Neo System |
| Philips North America LLC | $26.16 | 2025 | Ice 3d |
| E.R. Squibb & Sons, L.L.C. | $24.95 | 2025 | Camzyos |
| Medtronic, INC. | $23.61 | 2025 | Azure Xt Dr Mri Surescan |
| Bayer Healthcare Pharmaceuticals INC. | $21.91 | 2025 | |
| Biotronik INC. | $19.61 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrii Labchuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.